OBJECTIVE: To assess the potential effectiveness of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes. RESEARCH DESIGN AND METHODS: Individuals with a family history of diabetes were randomized to receive risk information based on familial and general risk factors (n = 59) or general risk factors alone (n = 59). Outcomes were assessed using questionnaires at baseline, 1 week, and 3 months. RESULTS: Compared with individuals receiving general risk information, those receiving familial risk information perceived heredity to be a more important cause of diabetes (P <0.01) at 1-week follow-up, perceived greater control over preventing diabetes (P <0.05), and reported having eaten more healthily...
ArIn the fight against the type 2 diabetes epidemic, patients might be asked to discuss familial sus...
Abstract Background Common disease risk clusters in families due to shared genetics, exposure to env...
OBJECTIVE—Rapid advances in diabetes genetic epidemiology may lead to a new era of “personalized med...
OBJECTIVE - To assess the potential effectiveness of communicating familial risk of diabetes on illn...
OBJECTIVE — To assess the potential effectiveness of communicating familial risk of diabe-tes on ill...
OBJECTIVE — To assess the potential effectiveness of communicating familial risk of diabe-tes on ill...
OBJECTIVE — This study aimed to assess the potential for communication of familial risk by patients ...
Patients with Type 2 diabetes may play a role as intermediary between medical professionals and at-r...
Family health history (FHH) in the context of risk assessment has been shown to positively impact ri...
Abstract Background A strong family history of type 2 diabetes mellitus (DM) confers increased DM ri...
BACKGROUND: Patients with type 2 diabetes can have an important role in discussing health risk withi...
OBJECTIVEdTo test the association of family history of diabetes with the adoption of di-abetes risk–...
Information about genetic and phenotypic risk of type 2 diabetes is now widely available and is bein...
Abstract Background Patients with type 2 diabetes can have an important role in discussing health ri...
INTRODUCTION: The aim of this study was to explore the perceptions of causes, risk, and control with...
ArIn the fight against the type 2 diabetes epidemic, patients might be asked to discuss familial sus...
Abstract Background Common disease risk clusters in families due to shared genetics, exposure to env...
OBJECTIVE—Rapid advances in diabetes genetic epidemiology may lead to a new era of “personalized med...
OBJECTIVE - To assess the potential effectiveness of communicating familial risk of diabetes on illn...
OBJECTIVE — To assess the potential effectiveness of communicating familial risk of diabe-tes on ill...
OBJECTIVE — To assess the potential effectiveness of communicating familial risk of diabe-tes on ill...
OBJECTIVE — This study aimed to assess the potential for communication of familial risk by patients ...
Patients with Type 2 diabetes may play a role as intermediary between medical professionals and at-r...
Family health history (FHH) in the context of risk assessment has been shown to positively impact ri...
Abstract Background A strong family history of type 2 diabetes mellitus (DM) confers increased DM ri...
BACKGROUND: Patients with type 2 diabetes can have an important role in discussing health risk withi...
OBJECTIVEdTo test the association of family history of diabetes with the adoption of di-abetes risk–...
Information about genetic and phenotypic risk of type 2 diabetes is now widely available and is bein...
Abstract Background Patients with type 2 diabetes can have an important role in discussing health ri...
INTRODUCTION: The aim of this study was to explore the perceptions of causes, risk, and control with...
ArIn the fight against the type 2 diabetes epidemic, patients might be asked to discuss familial sus...
Abstract Background Common disease risk clusters in families due to shared genetics, exposure to env...
OBJECTIVE—Rapid advances in diabetes genetic epidemiology may lead to a new era of “personalized med...